Loading clinical trials...
Loading clinical trials...
An Open-Label, Two-Period, Randomized, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Single Doses of Pazopanib in Cancer Patients
Conditions
Interventions
Pazopanib (GW786034)
Locations
2
United States
GSK Investigational Site
Indianapolis, Indiana, United States
GSK Investigational Site
Detroit, Michigan, United States
Start Date
September 21, 2006
Primary Completion Date
June 19, 2009
Completion Date
June 19, 2009
Last Updated
November 17, 2017
NCT07227415
NCT05127824
NCT05865730
NCT05239728
NCT04028245
NCT04338269
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions